Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05754450
PHASE3
An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II
Sponsor: AUG Therapeutics
View on ClinicalTrials.gov
Summary
The primary objective of this extension study is to assess the long-term safety and efficacy of AVTX-803 in subjects with LAD II (SLC35C1-CDG).
Official title: A Phase 3, Open-Label, Extension Study to Assess the Long-term Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II (LAD II)
Key Details
Gender
All
Age Range
6 Months - 75 Years
Study Type
INTERVENTIONAL
Enrollment
2
Start Date
2023-04-10
Completion Date
2026-12-31
Last Updated
2026-05-01
Healthy Volunteers
No
Conditions
Interventions
DRUG
AVTX-803
L-fucose crystalline powder
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States